UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $420

Benzinga · 3d ago
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $380 to $420.